By Jovenal M. Francisco, Contributor

HONG KONG — Asian health officials and cancer advocates are making decisive progress toward establishing the Asian Code Against Cancer (ACAC), a landmark public health framework designed to deliver culturally tailored, evidence-based cancer prevention strategies across the region.

The progress report was presented during a key session at the World Cancer Congress in Hong Kong, where representatives from the World Health Organization (WHO) and regional oncology organizations said crucial preliminary milestones have been achieved. The momentum follows the recent submission of findings by a multidisciplinary panel of senior oncologists, public health practitioners, and researchers working alongside their respective health ministries.

“We are excited at this development… because we are really turning evidence into actionable recommendations,” said Dr. Eric Domingo of the WHO Pacific Regional Office. “We already have codes in Europe and Latin America — why not one more for Asia? We are looking forward to making this happen very soon.”

While an official release date has yet to be announced, officials expressed confidence that the framework will be finalized swiftly. For those tracking the initiative, the milestones to watch next are the code's formal release and its ratification by member states — the step that would allow governments to begin aligning national strategies with the shared benchmarks the framework is set to establish.

Bridging the Regional Gap

The push for a unified code began five years ago under the Asian National Cancer Centers Alliance (ANCCA), a coalition now in its 20th year that aims to help Asia catch up with established regional models in Europe and Latin America.

Asia is home to nearly 60% of the global population and carries a disproportionate share of the world's cancer burden. The Western Pacific region alone accounts for one-third of all global cancer cases and related deaths. Yet only a handful of Asian nations — including China, Japan, and South Korea — currently possess formal, standalone national cancer prevention codes, meaning the majority of countries across the region lack a dedicated prevention code of their own.

That gap is precisely what a regional code is designed to close. Regional codes function as comprehensive public health toolkits, helping governments formulate cancer control policies while educating the public on lifestyle risks and early detection programs. For nations still without standalone codes, the ACAC is intended to serve as a common starting point grounded in the region's own evidence.

Dr. Domingo emphasized that a region-specific framework is essential because Asian nations share distinct dietary habits, lifestyles, cultural beliefs, traditions, and metabolic baselines.

Legal Foundations and Regional Cooperation

Legal experts highlighted that a cohesive framework will help bridge healthcare disparities across the region's diverse economies.

“We need a culturally and contextually adapted code that makes it easier to establish a legal basis to integrate at the domestic level,” said Ma-Anne Rosales Sto. Domingo of the McCabe Center for Law and Cancer. “We need a unifying code to promote regional cooperation — a regional framework where, despite varying capacities, no country gets left behind.”

Once ratified, the ACAC will enable member states to refine their national health strategies by sharing cross-border data and success stories. The framework will focus specifically on identifying risk factors unique to Asian populations, implementing evidence-based screening and early detection practices proven successful in neighboring countries, and setting standardized benchmarks for post-treatment survivorship care.

Economic and Public Health Impact

Health leaders argue that funding cancer prevention offers a significant economic advantage for developing and developed nations alike. Dr. Andrew Yuen of the Hong Kong Cancer Fund called on regional leaders to treat the upcoming code as a primary investment priority.

“By investing in this framework, governments and local leaders can transform the economic trajectory of oncology in Asia,” Mr. Yuen stated. “We can dramatically reduce cancer incidence, alleviate financial toxicity for millions of families, and deliver unprecedented return on healthcare investment across the region.”

That call to action now awaits the code's formal debut — with officials signaling the wait should not be long, even as the timeline for ratification remains to be set.